Crescent Capital BDC (NASDAQ:CCAP) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $20.00 to $19.00. They now have an "outperform" rating on the stock.
Crescent Capital BDC (NASDAQ:CCAP) had its price target lowered by analysts at Wells Fargo & Company from $15.00 to $14.00. They now have an "equal weight" rating on the stock.
Crescent Capital BDC (NASDAQ:CCAP) had its price target lowered by analysts at Keefe, Bruyette & Woods from $17.00 to $15.50. They now have an "outperform" rating on the stock.
Crescent Capital BDC, Inc. (CCAP) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Crescent Capital BDC declares $0.42 dividend [Seeking Alpha]